Skip to content
2000
image of The Bidirectional Relationship between Psoriatic Arthritis and Mental Health: A Comprehensive Review

Abstract

Introduction

Psoriatic arthritis (PsA) is a long-standing inflammatory immune-mediated condition that involves articular and peri-articular tissues and frequently accompanies psoriasis (PsO). It is defined by chronic joint inflammation, pain, and structural damage, resulting in impairment of physical function and quality of life. Increasing evidence points to the close relationship between PsA and mental disorders, especially depression and anxiety.

Methods

This review utilized an extensive literature search approach to select studies addressing the correlation between psoriatic arthritis (PsA) and mental comorbidities such as depression, anxiety, and their influence on quality of life and the disease course. Databases like PubMed, Scopus, Web of Science, and Google Scholar were utilized up to 2024 with applicable keywords and Boolean operators.

Results

The mutual interaction between PsA and psychological distress is moderated by mechanisms including chronic pain, systemic inflammation, physical disability, and the social stigma of psoriatic lesions. Research suggests that patients with PsA exhibit an increased frequency of anxiety and depression in comparison to the general population, and that mental illness augments the severity of the disease and affects the outcome of treatments adversely. In addition, PsA may also cause systemic inflammation that might lead to neurocognitive dysfunction, adding to the risk for mood disorders.

Discussion

Although there is a long-standing, well-documented psychosocial morbidity associated with PsA, mental health comorbidities are frequently underdiagnosed and undertreated. Psychological distress must be treated as an integral part of PsA management to enhance patient-reported outcomes as well as quality of life.

Conclusion

This review examines the complex interaction between PsA and mental health, considers the possible underlying mechanisms, and highlights the necessity of an integrated, multidisciplinary treatment strategy for patients.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/crr/10.2174/0115733971402784250807191227
2025-08-15
2025-11-01

  • From This Site

    /content/journals/crr/10.2174/0115733971402784250807191227
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Elliott A McGonagle D Rooney M. Integrating imaging and biomarker assessment to better define psoriatic arthritis and predict response to biologic therapy. Rheumatology 2021 60 Suppl 6 vi38 vi52 10.1093/rheumatology/keab504
    [Google Scholar]
  2. Pennington SR FitzGerald O Early origins of psoriatic arthritis: Clinical, genetic and molecular biomarkers of progression from psoriasis to psoriatic arthritis. Front. Med. 2021 8 723944 10.3389/fmed.2021.723944
    [Google Scholar]
  3. Woo YR Park CJ Kang H Kim JE The risk of systemic diseases in those with psoriasis and psoriatic arthritis: From mechanisms to clinic. Int. J. Mol. Sci. 2020 21 19 7041 10.3390/ijms21197041
    [Google Scholar]
  4. Sollid L.M. Pos W. Wucherpfennig K.W. Molecular mechanisms for contribution of MHC molecules to autoimmune diseases. Curr. Opin. Immunol. 2014 31 24 30 10.1016/j.coi.2014.08.005 25216261
    [Google Scholar]
  5. James L. The impact of psoriatic arthritis on quality of life: A systematic review. Ther. Adv. Musculoskelet. Dis. 2024 1759720X241295920 10.1177/1759720X241295920
    [Google Scholar]
  6. Bu J. Ding R. Zhou L. Chen X. Shen E. Epidemiology of psoriasis and comorbid diseases: A narrative review. Front. Immunol. 2022 13 880201 10.3389/fimmu.2022.880201 35757712
    [Google Scholar]
  7. Zhao S.S. Miller N. Harrison N. Duffield S.J. Dey M. Goodson N.J. Systematic review of mental health comorbidities in psoriatic arthritis. Clin. Rheumatol. 2020 39 1 217 225 10.1007/s10067‑019‑04734‑8 31486931
    [Google Scholar]
  8. Chmielewski G. Majewski M.S. Kuna J. Mikiewicz M. Krajewska-Włodarczyk M. Fatigue in inflammatory joint diseases. Int. J. Mol. Sci. 2023 24 15 12040 10.3390/ijms241512040 37569413
    [Google Scholar]
  9. Parkinson J.T. Depression in patients with spondyloarthritis: Prevalence, incidence, risk factors, mechanisms and management. Ther. Adv. Musculoskelet. Dis. 2020 1759720X20970028 10.1177/1759720X20970028
    [Google Scholar]
  10. Fabrazzo M. Cipolla S. Signoriello S. Camerlengo A. Calabrese G. Giordano G.M. Argenziano G. Galderisi S. A systematic review on shared biological mechanisms of depression and anxiety in comorbidity with psoriasis, atopic dermatitis, and hidradenitis suppurativa. Eur. Psychiatry 2021 64 1 71 10.1192/j.eurpsy.2021.2249 34819201
    [Google Scholar]
  11. Haugeberg G. Michelsen B. Kavanaugh A. Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: A cross-sectional study of outpatient clinic patients in the biologic treatment era. RMD Open 2020 6 1 001223 10.1136/rmdopen‑2020‑001223 32409518
    [Google Scholar]
  12. McDonough E. Ayearst R. Eder L. Chandran V. Rosen C.F. Thavaneswaran A. Gladman D.D. Depression and anxiety in psoriatic disease: Prevalence and associated factors. J. Rheumatol. 2014 41 5 887 896 10.3899/jrheum.130797 24692521
    [Google Scholar]
  13. Chander A. Sharma J. Mahajan S. Dhankhar S. Chauhan S. Saini M. Mehta S. Serotonergic dynamics in autism spectrum disorder: Unraveling the intricate connection. CNS Neurol. Disord. Drug Targets 2025 24 7 511 520 10.2174/0118715273378214250213114328
    [Google Scholar]
  14. Dhankhar S. Mujwar S. Garg N. Chauhan S. Saini M. Sharma P. Kumar S. Kumar Sharma S. Kamal M.A. Rani N. Artificial intelligence in the management of neurodegenerative disorders. CNS Neurol. Disord. Drug Targets 2024 23 8 931 940 10.2174/0118715273266095231009092603 37861051
    [Google Scholar]
  15. Garg N. Dhankhar S. Dhariya A. Parkash C. Chauhan S. Singh T.G. Role of liposomes in the treatment of neurodegenerative disorders: A comprehensive review. Cent. Nerv. Syst. Agents Med. Chem. 2025 25 1 17 10.2174/0118715249342585241230065557
    [Google Scholar]
  16. Thapa K. Khan H. Chahuan S. Dhankhar S. Kaur A. Garg N. Saini M. Singh T.G. Insights into therapeutic approaches for the treatment of neurodegenerative diseases targeting metabolic syndrome. Mol. Biol. Rep. 2025 52 1 260 10.1007/s11033‑025‑10346‑0 39982557
    [Google Scholar]
  17. James C. Brunckhorst O. Eymech O. Stewart R. Dasgupta P. Ahmed K. Fear of cancer recurrence and PSA anxiety in patients with prostate cancer: A systematic review. Support. Care Cancer 2022 30 7 5577 5589 10.1007/s00520‑022‑06876‑z 35106656
    [Google Scholar]
  18. Dures E. Shepperd S. Mukherjee S. Robson J. Vlaev I. Walsh N. Coates L.C. Treat-to-target in PsA: Methods and necessity. RMD Open 2020 6 1 001083 10.1136/rmdopen‑2019‑001083 32071281
    [Google Scholar]
  19. Gialouri C. Evangelatos G. Zhao S.S. Kouna K. Karamanakos A. Iliopoulos A. Tektonidou M.G. Sfikakis P.P. Fragoulis G.E. Depression and anxiety in a real-world psoriatic arthritis longitudinal study: Should we focus more on patients’ perception? Clin. Exp. Rheumatol. 2022 41 1 159 165 10.55563/clinexprheumatol/8qxo80 35819812
    [Google Scholar]
  20. Mathew A.J. Chandran V. Depression in psoriatic arthritis: Dimensional aspects and link with systemic inflammation. Rheumatol. Ther. 2020 7 2 287 300 10.1007/s40744‑020‑00207‑6 32323218
    [Google Scholar]
  21. Rohilla S. Sharma P. Kamboj S. Dhankhar S. Garg N. Chauhan S. Rani N. Anabolic androgenic steroids: A review. Emir. Med. J. 2024 5 02506882253706 10.2174/0102506882253706240104073440
    [Google Scholar]
  22. Schön MP Adaptive and innate immunity in psoriasis and other inflammatory disorders. Front. Immunol. 2019 10 1764 10.3389/fimmu.2019.01764
    [Google Scholar]
  23. Batko B. Exploring the diverse immune and genetic landscape of psoriatic arthritis. J. Clin. Med. 2021 10 24 5926 10.3390/jcm10245926 34945224
    [Google Scholar]
  24. Petersdorf E.W. O’hUigin C. The MHC in the era of next-generation sequencing: Implications for bridging structure with function. Hum. Immunol. 2019 80 1 67 78 10.1016/j.humimm.2018.10.002 30321633
    [Google Scholar]
  25. Chen L Tsai TF HLA-Cw6 and psoriasis. Br. J. Dermatol. 2018 178 4 854 862 10.1111/bjd.16083
    [Google Scholar]
  26. Dhankhar S. Kumar J. Chauhan S. Zahoor I. Wani S.N. Saini M. Borsha J.A. Yasmin S. Ansari M.Y. Flavonoids and flavonoid-based nanoparticles for the treatment of arthritis. Inflammopharmacology 2025 33 5 2193 2216 10.1007/s10787‑025‑01722‑0 40156677
    [Google Scholar]
  27. Gaffen S.L. Jain R. Garg A.V. Cua D.J. The IL-23–IL-17 immune axis: From mechanisms to therapeutic testing. Nat. Rev. Immunol. 2014 14 9 585 600 10.1038/nri3707 25145755
    [Google Scholar]
  28. Chua-Aguilera C.J. Möller B. Yawalkar N. Skin manifestations of rheumatoid arthritis, juvenile idiopathic arthritis, and spondyloarthritides. Clin. Rev. Allergy Immunol. 2017 53 3 371 393 10.1007/s12016‑017‑8632‑5 28752373
    [Google Scholar]
  29. Fusco M. Skaper S.D. Coaccioli S. Varrassi G. Paladini A. Degenerative joint diseases and neuroinflammation. Pain Pract. 2017 17 4 522 532 10.1111/papr.12551 28039964
    [Google Scholar]
  30. Caso F. Psoriatic arthritis. Mosaic of autoimmunity. Amsterdam, Netherlands Elsevier 2019 527 540 10.1016/B978‑0‑12‑814307‑0.00047‑5
    [Google Scholar]
  31. Diani M. Altomare G. Reali E. T cell responses in psoriasis and psoriatic arthritis. Autoimmun. Rev. 2015 14 4 286 292 10.1016/j.autrev.2014.11.012 25445403
    [Google Scholar]
  32. Shi L. Liu C. Xiong H. Shi D. Elevation of IgE in patients with psoriasis: Is it a paradoxical phenomenon? Front. Med. 2022 9 1007892 10.3389/fmed.2022.1007892 36314037
    [Google Scholar]
  33. De Andrea M. De Santis M. Caneparo V. Generali E. Sirotti S. Isailovic N. Guidelli G.M. Ceribelli A. Fabbroni M. Simpatico A. Cantarini L. Gisondi P. Idolazzi L. Gariglio M. Selmi C. Serum IFI16 and anti-IFI16 antibodies in psoriatic arthritis. Clin. Exp. Immunol. 2019 199 1 88 96 10.1111/cei.13376 31571199
    [Google Scholar]
  34. Neurath L. Sticherling M. Schett G. Fagni F. Targeting cytokines in psoriatic arthritis. Cytokine Growth Factor Rev. 2024 78 1 13 10.1016/j.cytogfr.2024.06.001 39068140
    [Google Scholar]
  35. Lee B. Lee S.H. Shin K. Crosstalk between fibroblasts and T cells in immune networks. Front. Immunol. 2023 13 1103823 10.3389/fimmu.2022.1103823 36700220
    [Google Scholar]
  36. Azuaga A.B. Ramírez J. Cañete J.D. Psoriatic arthritis: Pathogenesis and targeted therapies. Int. J. Mol. Sci. 2023 24 5 4901 10.3390/ijms24054901 36902329
    [Google Scholar]
  37. Blauvelt A. Chiricozzi A. The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis. Clin. Rev. Allergy Immunol. 2018 55 3 379 390 10.1007/s12016‑018‑8702‑3 30109481
    [Google Scholar]
  38. Lee B.W. Moon S.J. Inflammatory cytokines in psoriatic arthritis: Understanding pathogenesis and implications for treatment. Int. J. Mol. Sci. 2023 24 14 11662 10.3390/ijms241411662 37511421
    [Google Scholar]
  39. Gallo J. Raska M. Kriegova E. Goodman S.B. Inflammation and its resolution and the musculoskeletal system. J. Orthop. Translat. 2017 10 52 67 10.1016/j.jot.2017.05.007 28781962
    [Google Scholar]
  40. Kishimoto M. Deshpande G.A. Fukuoka K. Kawakami T. Ikegaya N. Kawashima S. Komagata Y. Kaname S. Clinical features of psoriatic arthritis. Best Pract. Res. Clin. Rheumatol. 2021 35 2 101670 10.1016/j.berh.2021.101670 33744078
    [Google Scholar]
  41. Cheatle M.D. Foster S. Pinkett A. Lesneski M. Qu D. Dhingra L. Assessing and managing sleep disturbance in patients with chronic pain. Anesthesiol. Clin. 2016 34 2 379 393 10.1016/j.anclin.2016.01.007 27208716
    [Google Scholar]
  42. Martínez-Ortega J.M. Nogueras P. Muñoz-Negro J.E. Gutiérrez-Rojas L. González-Domenech P. Gurpegui M. Quality of life, anxiety and depressive symptoms in patients with psoriasis: A case-control study. J. Psychosom. Res. 2019 124 109780 10.1016/j.jpsychores.2019.109780 31443809
    [Google Scholar]
  43. Lewinson R.T. Vallerand I.A. Lowerison M.W. Parsons L.M. Frolkis A.D. Kaplan G.G. Bulloch A.G.M. Swain M.G. Patten S.B. Barnabe C. Depression is associated with an increased risk of psoriatic arthritis among patients with psoriasis: A population-based study. J. Invest. Dermatol. 2017 137 4 828 835 10.1016/j.jid.2016.11.032 28237512
    [Google Scholar]
  44. Kannayiram S. Schmukler J. Li T. Goodson N. Sridhar A. Pincus T. Elevated DAS28-ESR in patients with rheumatoid arthritis who have comorbid fibromyalgia is associated more with tender joint counts than with patient global assessment or swollen joint counts: Implications for assessment of inflammatory activity. Clin. Exp. Rheumatol. 2024 42 5 1083 1090 38525998
    [Google Scholar]
  45. Yu Y.H. Zhang S-Q. Li Q. Li W. Zhou X. Xue R-J. Liang J-Y. Zhang X-B. Epidemiology of depression and suicide ideation in patients with psoriasis: A meta-analysis of prospective cohort studies. Inter. J. Dermat. Venereol. 2023 6 2 78 86 10.1097/JD9.0000000000000307
    [Google Scholar]
  46. Blackstone B Patel R Bewley A. Assessing and improving psychological well-being in psoriasis: Considerations for the clinician. Psoriasis 2022 12 25 33 10.2147/PTT.S328447
    [Google Scholar]
  47. Mease P.J. Liu M. Rebello S. Kang H. Yi E. Park Y. Greenberg J.D. Comparative disease burden in patients with rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis: Data from two Corrona registries. Rheumatol. Ther. 2019 6 4 529 542 10.1007/s40744‑019‑00172‑9 31529278
    [Google Scholar]
  48. Batko B. Patient-centered care in psoriatic arthritis—a perspective on inflammation, disease activity, and psychosocial factors. J. Clin. Med. 2020 9 10 3103 10.3390/jcm9103103 32992983
    [Google Scholar]
  49. Rida M.A. Chandran V. Challenges in the clinical diagnosis of psoriatic arthritis. Clin. Immunol. 2020 214 108390 10.1016/j.clim.2020.108390 32200113
    [Google Scholar]
  50. Patel N. Nadkarni A. Cardwell L.A. Vera N. Frey C. Patel N. Feldman S.R. Psoriasis, depression, and inflammatory overlap: A review. Am. J. Clin. Dermatol. 2017 18 5 613 620 10.1007/s40257‑017‑0279‑8 28432649
    [Google Scholar]
  51. Nowowiejska J. Baran A. Flisiak I. Mutual relationship between sleep disorders, quality of life and psychosocial aspects in patients with psoriasis. Front. Psychiatry 2021 12 674460 10.3389/fpsyt.2021.674460 34295272
    [Google Scholar]
  52. Lubrano E. Scriffignano S. Perrotta F.M. TNF-alpha inhibitors for the six treatment targets of psoriatic arthritis. Expert Rev. Clin. Immunol. 2019 15 12 1303 1312 10.1080/1744666X.2020.1685382 31652079
    [Google Scholar]
  53. Papp K. Valenzuela F. Poulin Y. Bernstein G. Wasel N. Epidemiology of moderate-to-severe plaque psoriasis in a Canadian surveyed population. J. Cutan. Med. Surg. 2010 14 4 167 174 10.2310/7750.2010.09066 20642985
    [Google Scholar]
  54. Bhushan V. Lester S. Briggs L. Hijjawi R. Shanahan E.M. Pontifex E. Ninan J. Hill C. Cai F. Walker J. Goldblatt F. Wechalekar M.D. Real-life retention rates and reasons for switching of biological DMARDs in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Front. Med. 2021 8 708168 10.3389/fmed.2021.708168 34646840
    [Google Scholar]
  55. Eicher L. Knop M. Aszodi N. Senner S. French L.E. Wollenberg A. A systematic review of factors influencing treatment adherence in chronic inflammatory skin disease – strategies for optimizing treatment outcome. J. Eur. Acad. Dermatol. Venereol. 2019 33 12 2253 2263 10.1111/jdv.15913 31454113
    [Google Scholar]
  56. Richard M.A. Paul C. Nijsten T. Gisondi P. Salavastru C. Taieb C. Stratigos A. Trakatelli M. Puig L. The journey of patients with skin diseases from the first consultation to the diagnosis in a representative sample of the European general population from the EADV burden of skin diseases study. J. Eur. Acad. Dermatol. Venereol. 2023 37 S7 17 24 10.1111/jdv.18916 37806003
    [Google Scholar]
  57. Prignano F. Campione E. Parodi A. Vegni E. Bardazzi F. Borroni R.G. Burlando M. Cinotti E. Dini V. Giacchetti A. Giofrè C. Megna M. Zichichi L. Fargnoli M.C. Empathy life in psoriasis: Embracing patients’ well-being in their journey of moderate- to-severe psoriasis. J. Clin. Med. 2024 13 15 4469 10.3390/jcm13154469 39124737
    [Google Scholar]
  58. Lubrano E. Ambrosino P. Perrotta F.M. Psychological health in the management of patients with psoriatic arthritis: An intricate relationship. Rheumatol. Ther. 2025 12 3 407 419 10.1007/s40744‑025‑00759‑5 40133582
    [Google Scholar]
  59. Huber-Lang M. Lambris J.D. Ward P.A. Innate immune responses to trauma. Nat. Immunol. 2018 19 4 327 341 10.1038/s41590‑018‑0064‑8 29507356
    [Google Scholar]
  60. Husni M.E. Merola J.F. Davin S. The psychosocial burden of psoriatic arthritis. Seminars in arthritis and rheumatism. Amsterdam, Netherlands Elsevier 2017 10.1016/j.semarthrit.2017.05.010
    [Google Scholar]
  61. Ovsiannikova Y. Pokhilko D. Kerdyvar V. Krasnokutsky M. Kosolapov O. Peculiarities of the impact of stress on physical and psychological health. Multidisciplinary Sci. J. 2024 6 2024ss0711 10.31893/multiscience.2024ss0711
    [Google Scholar]
  62. Sic A. Cvetkovic K. Manchanda E. Knezevic N.N. Neurobiological implications of chronic stress and metabolic dysregulation in inflammatory bowel diseases. Diseases 2024 12 9 220 10.3390/diseases12090220 39329889
    [Google Scholar]
  63. Wilk M. Łosińska K. Pripp A.H. Korkosz M. Haugeberg G. Pain catastrophizing in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: Biopsychosocial perspective and impact on health-related quality of life. Rheumatol. Int. 2022 42 4 669 682 10.1007/s00296‑021‑05070‑4 35098329
    [Google Scholar]
  64. Rush A.J. Thase M.E. Improving depression outcome by patient- centered medical management. Am. J. Psychiatry 2018 175 12 1187 1198 10.1176/appi.ajp.2018.18040398 30220219
    [Google Scholar]
  65. Mpofana N. Psoriasis: Clinical features and its impact on quality of life. Psoriasis - Recent advances in diagnosis and treatment. United Kingdom IntechOpen 2024 10.5772/intechopen.1005098
    [Google Scholar]
  66. Aldhouse N.V.J. Kitchen H. Knight S. Macey J. Nunes F.P. Dutronc Y. Mesinkovska N. Ko J.M. King B.A. Wyrwich K.W. “‘You lose your hair, what’s the big deal?’ I was so embarrassed, I was so self-conscious, I was so depressed:” a qualitative interview study to understand the psychosocial burden of alopecia areata. J. Patient. Rep. Outcomes 2020 4 1 76 10.1186/s41687‑020‑00240‑7 32914253
    [Google Scholar]
  67. Sarkodie-Gyan T. Yu H. Challenges and concerns to society: The human locomotor system. The Human Locomotor System. Cham Springer 2023 pp. 99-122. 10.1007/978‑3‑031‑32781‑0_3
    [Google Scholar]
  68. Walsh J.A. Adejoro O. Chastek B. Chun G. Palmer J.B. SAT0456 Therapy modifications among patients with psoriatic arthritis treated with a biologic in the united states – descriptive analyses from an administrative claims database. Ann. Rheum. Dis. 2017 76 945 946 10.1136/annrheumdis‑2017‑eular.3014
    [Google Scholar]
  69. Diachkova O. Yeremenko L. Donets I. Klymenko I. Kononenko A. Harnessing positive thinking: A cognitive behavioural approach to stress management. Inter. J. Rel. 2024 5 9 380 389 10.61707/tb42sg22
    [Google Scholar]
  70. Redekop W.K. Mladsi D. The faces of personalized medicine: A framework for understanding its meaning and scope. Value Health 2013 16 6 S4 S9 10.1016/j.jval.2013.06.005 24034312
    [Google Scholar]
  71. Krist A.H. Tong S.T. Aycock R.A. Longo D.R. Engaging patients in decision-making and behavior change to promote prevention. Inf. Serv. Use 2017 37 2 105 122 10.3233/ISU‑170826 28972524
    [Google Scholar]
  72. Brom L. Pasman H.R.W. Widdershoven G.A.M. van der Vorst M.J.D.L. Reijneveld J.C. Postma T.J. Onwuteaka-Philipsen B.D. Patients’ preferences for participation in treatment decision-making at the end of life: Qualitative interviews with advanced cancer patients. PLoS One 2014 9 6 100435 10.1371/journal.pone.0100435 24964036
    [Google Scholar]
  73. Woźniak E. Owczarczyk-Saczonek A. Placek W. Psychological stress, mast cells, and psoriasis—is there any relationship? Int. J. Mol. Sci. 2021 22 24 13252 10.3390/ijms222413252 34948049
    [Google Scholar]
  74. Foks-Ciekalska A. The vicious circle effect: Stress as effect and cause in patients with psoriasis. Postepy Dermatol. Alergol. 2023 40 3 362 367 10.5114/ada.2022.120452
    [Google Scholar]
  75. Paulis G. Inflammatory mechanisms and oxidative stress in prostatitis: The possible role of antioxidant therapy. Res. Rep. Urol. 2018 10 75 87 10.2147/RRU.S170400 30271757
    [Google Scholar]
  76. Geetanjali A.S. Wahane A. Sharma A. Exploring effective strategies for stress management: Enhancing mental well-being through mindfulness, CBT, exercise, and relaxation techniques. Bull. Indones. Econ. Stud. 2023 12 345 348 10.4236/psych.2024.155049
    [Google Scholar]
  77. Barnes T.R.E. Drake R. Paton C. Cooper S.J. Deakin B. Ferrier I.N. Gregory C.J. Haddad P.M. Howes O.D. Jones I. Joyce E.M. Lewis S. Lingford-Hughes A. MacCabe J.H. Owens D.C. Patel M.X. Sinclair J.M.A. Stone J.M. Talbot P.S. Upthegrove R. Wieck A. Yung A.R. Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology. J. Psychopharmacol. 2020 34 1 3 78 10.1177/0269881119889296 31829775
    [Google Scholar]
  78. Pepe M. Lanzotti P. Mazza M. Hypnotics: Course and duration of therapy, side effects, contraindications, interactions, withdrawal syndromes, and resistance to therapy. NeuroPsychopharmacotherapy. Cham Springer 2021 pp. 1-28. 10.1007/978‑3‑319‑56015‑1_455‑1
    [Google Scholar]
  79. Chan S.J. Yeo H.Y. Stamp L.K. Treharne G.J. Marra C.A. What are the preferences of patients with rheumatoid arthritis for treatment modification? A scoping review. Patient 2021 14 5 505 532 10.1007/s40271‑020‑00488‑7 33336324
    [Google Scholar]
  80. Lwin M.N. Serhal L. Holroyd C. Edwards C.J. Rheumatoid arthritis: The impact of mental health on disease: A narrative review. Rheumatol. Ther. 2020 7 3 457 471 10.1007/s40744‑020‑00217‑4 32535834
    [Google Scholar]
  81. Vasilakis-Scaramozza C. Persson R. Hagberg K.W. Jick S. The risk of treated anxiety and treated depression among patients with psoriasis and psoriatic arthritis treated with apremilast compared to biologics, DMARDs and corticosteroids: A cohort study in the United States MarketScan database. J. Eur. Acad. Dermatol. Venereol. 2020 34 8 1755 1763 10.1111/jdv.16231 31981426
    [Google Scholar]
  82. Watson E. Shinkins B. Frith E. Neal D. Hamdy F. Walter F. Weller D. Wilkinson C. Faithfull S. Wolstenholme J. Sooriakumaran P. Kastner C. Campbell C. Neal R. Butcher H. Matthews M. Perera R. Rose P. Symptoms, unmet needs, psychological well-being and health status in survivors of prostate cancer: Implications for redesigning follow-up. BJU Int. 2016 117 6B E10 E19 10.1111/bju.13122 25818406
    [Google Scholar]
  83. Laure G. Xenofon B. Andreas K. de Wit Maarten EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Ann. Rheum. Dis. 2020 79 6 700 712 10.1136/annrheumdis‑2020‑217159
    [Google Scholar]
  84. Raad G. Tanios J. Azoury J. Daher A. Fakih C. Bakos H.W. Neurophysiology of cognitive behavioural therapy, deep breathing and progressive muscle relaxation used in conjunction with ART treatments: A narrative review. Hum. Reprod. Update 2021 27 2 324 338 10.1093/humupd/dmaa048 33238001
    [Google Scholar]
  85. Russell-Williams J. Jaroudi W. Perich T. Hoscheidt S. El Haj M. Moustafa A.A. Mindfulness and meditation: Treating cognitive impairment and reducing stress in dementia. Rev. Neurosci. 2018 29 7 791 804 10.1515/revneuro‑2017‑0066 29466242
    [Google Scholar]
  86. Dhankhar S. Cognitive rehabilitation for early-stage dementia: A review. Curr. Psych. Res. Rev. 2024 20 1 14 10.2174/0126660822275618231129073551
    [Google Scholar]
  87. van Huizen L.S. Dijkstra P.U. van der Laan B.F.A.M. Reintsema H. Ahaus K.T.B. Bijl H.P. Roodenburg J.L.N. Multidisciplinary first-day consultation accelerates diagnostic procedures and throughput times of patients in a head-and-neck cancer care pathway, a mixed method study. BMC Health Serv. Res. 2018 18 1 820 10.1186/s12913‑018‑3637‑1 30373578
    [Google Scholar]
  88. Silva F.A. Brito C. Araújo G. Fé I. Tyan M. Lee J.W. Nguyen T.A. Maciel P.R.M. Model-driven impact quantification of energy resource redundancy and server rejuvenation on the dependability of medical sensor networks in smart hospitals. Sensors 2022 22 4 1595 10.3390/s22041595 35214499
    [Google Scholar]
  89. Webb A-J. The role of mindfulness in acceptance and commitment therapy: Cultivating present-moment awareness. Auth. Prep. 2023 1 6 10.22541/au.169156286.65673666/v1
    [Google Scholar]
  90. Sui H. Guo M. Cognitive-behavioral stress management program reduces postoperative psychological pressure and improves life quality in prostate cancer patients. Ir. J. Med. Sci. 2024 193 2 645 652 10.1007/s11845‑023‑03520‑5
    [Google Scholar]
  91. Bonilla-Jaime H. Sánchez-Salcedo J.A. Estevez-Cabrera M.M. Molina-Jiménez T. Cortes-Altamirano J.L. Alfaro-Rodríguez A. Depression and pain: Use of antidepressants. Curr. Neuropharmacol. 2022 20 2 384 402 10.2174/1570159X19666210609161447 34151765
    [Google Scholar]
  92. Bertolín-Guillén J.M. Current state of psychopharmacology, psychotherapies and other interventions in mental health problems and disorders. Eur J Appl Sci 2021 9 5 10.1002/wps.20941
    [Google Scholar]
  93. Bukstein D.A. Patient adherence and effective communication. Ann. Allergy Asthma Immunol. 2016 117 6 613 619 10.1016/j.anai.2016.08.029 27979018
    [Google Scholar]
  94. Kingod N. Cleal B. Wahlberg A. Husted G.R. Online peer-to-peer communities in the daily lives of people with chronic illness: A qualitative systematic review. Qual. Health Res. 2017 27 1 89 99 10.1177/1049732316680203 27956659
    [Google Scholar]
  95. Kciuk M. Garg A. Rohilla M. Chaudhary R. Dhankhar S. Dhiman S. Bansal S. Saini M. Singh T.G. Chauhan S. Mujwar S. Gielecińska A. Kontek R. Therapeutic potential of plant-derived compounds and plant extracts in rheumatoid arthritis—comprehensive review. Antioxidants 2024 13 7 775 10.3390/antiox13070775 39061843
    [Google Scholar]
  96. Abild S.M. Maintaining good mental health in people with inflammatory arthritis: A qualitative study of patients' perspectives. Int. J. Qual. Stud. Health Well-being 2024 19 1 2424015 10.1080/17482631.2024.2424015
    [Google Scholar]
  97. Sharma H. Mahajan S. Garg N. Chauhan S. Saini M. Singh T.G. Dhankhar S. Mittal P. AI-powered solutions for casualty assessment in drug safety and patient care. Emir. Med. J. 2024 5 1 02506882313855 10.2174/0102506882313855240809064836
    [Google Scholar]
  98. Carniciu S. Hafi B. Gkini M-A. Tzellos T. Jafferany M. Stamu-O’Brien C. Secondary psychiatric disorders and the skin. Dermatol. Rev. 2023 4 4 162 171 10.1002/der2.211
    [Google Scholar]
  99. Cabrera V.J. Hansson J. Kliger A.S. Finkelstein F.O. Symptom management of the patient with CKD: The role of dialysis. Clin. J. Am. Soc. Nephrol. 2017 12 4 687 693 10.2215/CJN.01650216 28148557
    [Google Scholar]
  100. Nash R. Mental health in chronic and end-stage liver disease. Psychosocial Care of End-Stage Organ Disease and Transplant Patients. Cham Springer 2018 pp. 147-158. 10.1007/978‑3‑319‑94914‑7_12
    [Google Scholar]
  101. Kessler R.C. Demler O. Frank R.G. Olfson M. Pincus H.A. Walters E.E. Wang P. Wells K.B. Zaslavsky A.M. Prevalence and treatment of mental disorders, 1990 to 2003. N. Engl. J. Med. 2005 352 24 2515 2523 10.1056/NEJMsa043266 15958807
    [Google Scholar]
  102. Matcham F. Rayner L. Steer S. Hotopf M. The prevalence of depression in rheumatoid arthritis: A systematic review and meta-analysis. Rheumatology 2013 52 12 2136 2148 10.1093/rheumatology/ket169 24003249
    [Google Scholar]
  103. Dalgard F.J. Gieler U. Tomas-Aragones L. Lien L. Poot F. Jemec G.B.E. Misery L. Szabo C. Linder D. Sampogna F. Evers A.W.M. Halvorsen J.A. Balieva F. Szepietowski J. Romanov D. Marron S.E. Altunay I.K. Finlay A.Y. Salek S.S. Kupfer J. The psychological burden of skin diseases: A cross-sectional multicenter study among dermatological out-patients in 13 European countries. J. Invest. Dermatol. 2015 135 4 984 991 10.1038/jid.2014.530 25521458
    [Google Scholar]
  104. Matthews R. Ali Z. Comorbid mental health issues in patients with pemphigus vulgaris and pemphigus foliaceus. Clin. Exp. Dermatol. 2022 47 1 24 29 10.1111/ced.14916 34459019
    [Google Scholar]
  105. Palmer S. Vecchio M. Craig J.C. Tonelli M. Johnson D.W. Nicolucci A. Pellegrini F. Saglimbene V. Logroscino G. Fishbane S. Strippoli G.F.M. Prevalence of depression in chronic kidney disease: Systematic review and meta-analysis of observational studies. Kidney Int. 2013 84 1 179 191 10.1038/ki.2013.77 23486521
    [Google Scholar]
  106. Hansen L. Physical and mental quality of life in patients with end-stage liver disease and their informal caregivers. Clin. Gastroenterol. Hepatol. 2021 19 1 155 161.e1 10.1016/j.cgh.2020.04.014
    [Google Scholar]
  107. Maurer J. Anxiety and depression in COPD: Current understanding, unanswered questions, and research needs. Rev. Port. Pneumol. 2009 15 4 740 742 10.1016/S0873‑2159(15)30172‑0 25965921
    [Google Scholar]
  108. Degboe Y. Vastert S.J. Prakken B.J. McInnes I.B. How does age determine the development of human immune-mediated arthritis? Nat. Rev. Rheumatol. 2022 18 9 501 512 10.1038/s41584‑022‑00814‑3 35948692
    [Google Scholar]
/content/journals/crr/10.2174/0115733971402784250807191227
Loading
The Bidirectional Relationship between Psoriatic Arthritis and Mental Health: A Comprehensive Review
Bentham Science Publishers ; https://doi.org/10.2174/0115733971402784250807191227
/content/journals/crr/10.2174/0115733971402784250807191227
/content/journals/crr/10.2174/0115733971402784250807191227
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: neurocognitive dysfunction ; Arthritis ; comorbidities ; psychological distress ; mental health ; depression ; psoriasis ; systemic inflammation ; anxiety

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test